Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Retrieved 2013-08-26
This leads to better blood sugar control, more stable energy levels, and a reduced tendency to store excess fat
It is expanding the GLP1 customer/patient base with 80% of patients new to therapy, driving economics into higher-priced doses, and optimistically starting to repair market confidence that was badly shaken by guidance cuts and competitive pressure from tirzepatide
Condition Location Conditions Locations Treatment Type Trial Phase Trial Status Paid Participation Trial Details Key Eligibility Criteria 4500 Participants Needed Trial Details Key Eligibility Criteria 1100 Participants Needed Trial Details Key Eligibility Criteria 280 Participants Needed Trial Details Key Eligibility Criteria 380 Participants Needed Trial Details Key Eligibility Criteria 148 Participants Needed Trial Details Key Eligibility Criteria 755 Participants Needed Trial Details Key Eligibility Criteria 250 Participants Needed Trial Details Key Eligibility Criteria 120 Participants Needed Trial Details Key Eligibility Criteria 206 Participants Needed Trial Details Key Eligibility Criteria 982 Participants Needed Trial Details Key Eligibility Criteria 1005 Participants Needed Trial Details Key Eligibility Criteria 263 Participants Needed Trial Details Key Eligibility Criteria 179 Participants Needed Trial Details Key Eligibility Criteria 120 Participants Needed Trial Details Key Eligibility Criteria 39 Participants Needed Trial Details Key Eligibility Criteria 300 Participants Needed Trial Details Key Eligibility Criteria 285 Participants Needed "I have tried to lose weight, but as I get older, it becomes harder and harder
US$ 25.41
US$ 20.16
US$ 24.55
US$ 23.67
US$ 21.56
US$ 25.24
US$ 27.63
US$ 20.66
US$ 26.22
